This non-significant difference (p=0.0766) is in good agreement with previous studies showing that BIL was liver-preferential and caused fewer hypoglycaemic events than conventional insulin treatment in individuals with diabetes [22, 34, 35]. This evidence concerns the gene INS and diabetes mellitus.